Cedars-Sinai 20th Annual Women and Ischemic Heart Disease Symposium 2026

Women’s Cardiovascular Health, MINOCA & Sex-Specific Ischemic Heart Disease CME Program

Introduction

The Cedars-Sinai 20th Annual Women and Ischemic Heart Disease Symposium 2026 is a specialized cardiovascular medicine program focused on sex-specific cardiovascular disease, ischemic heart disease in women, coronary microvascular dysfunction, MINOCA, HFpEF, lipid management, menopause-related cardiovascular risk, and cardiovascular complications during pregnancy. Presented by Cedars-Sinai, this advanced symposium provides evidence-based updates and practical clinical strategies for diagnosing and managing cardiovascular disease in women.

Cardiovascular disease remains the leading cause of death among women worldwide, yet important sex-specific differences in presentation, diagnosis, pathophysiology, and treatment continue to be underrecognized. Women frequently present with atypical symptoms, coronary microvascular dysfunction, MINOCA (myocardial infarction with non-obstructive coronary arteries), HFpEF, and pregnancy-related cardiovascular disorders that require distinct diagnostic and management approaches.

The Cedars-Sinai Women and Ischemic Heart Disease Symposium 2026 addresses these evolving clinical challenges through comprehensive education in:

• Women’s cardiovascular health
• Ischemic heart disease in women
• MINOCA
• Coronary microvascular dysfunction
• HFpEF
• Women’s heart disease
• Menopause and cardiovascular risk
• Hypertension in pregnancy
• Lipid management
• Lp(a) therapies
• GLP-1 receptor agonists
• Acute coronary syndrome in women
• Coronary function testing
• Preventive cardiology for women

The curriculum combines expert lectures, debates, case-based learning, and evidence-based discussions focused on optimizing cardiovascular care for women across diverse clinical settings.

You will find this course at medicalamboss.com

---

Course Overview

📚 Program: Cedars-Sinai 20th Annual Women and Ischemic Heart Disease Symposium 2026

🏛️ Presented by: Cedars-Sinai

📅 Course Date: Friday, April 17, 2026

📍 Location: Harvey Morse Conference Center, Los Angeles, California

🎥 Included Content

• 1 Video Lecture
• 1 Subtitle File (.vtt)
• 12 PDF Files

💾 Total Size: 1.02 GB

🎯 Educational Focus

• Women’s cardiovascular disease
• Ischemic heart disease
• MINOCA
• HFpEF
• Coronary microvascular dysfunction
• Menopause and heart disease
• Lipid management
• Pregnancy hypertension
• Preventive cardiology
• Coronary function testing

👨‍⚕️ Target Audience

• Cardiologists
• OB/GYN physicians
• Internists
• Women’s health specialists
• Preventive cardiology clinicians
• Advanced practice providers
• Cardiovascular trainees

---

Educational Focus

This advanced cardiovascular symposium delivers clinically relevant education in:

• Sex-specific cardiovascular medicine
• Coronary microvascular disease
• Women’s ischemic heart disease
• Preventive cardiology
• Advanced lipid therapies
• Menopause-associated cardiovascular risk
• HFpEF management
• Pregnancy-related hypertension

The curriculum emphasizes evidence-based strategies tailored to women’s cardiovascular health.

---

MINOCA & Ischemic Heart Disease in Women

A major component of the symposium focuses on myocardial infarction with non-obstructive coronary arteries (MINOCA).

Topics Include

• MINOCA diagnosis
• Coronary microvascular dysfunction
• Coronary vasospasm
• Ischemia with non-obstructive coronary disease
• Sex-specific ACS presentations
• Diagnostic accuracy in women

Participants review contemporary evidence regarding mechanisms, diagnosis, and treatment of ischemic syndromes unique to women.

---

HFpEF & Coronary Function Testing

Dedicated sessions explore advanced evaluation strategies in women with HFpEF and ischemic symptoms.

Covered Areas

• Invasive coronary function testing
• HFpEF evaluation
• Coronary endothelial dysfunction
• Hemodynamic assessment
• Invasive diagnostic techniques
• Women-specific heart failure considerations

The curriculum emphasizes practical application of advanced cardiovascular diagnostic strategies.

---

Lipid Management & Emerging Therapies

Specialized lectures review contemporary preventive cardiology therapies.

Educational Topics

• Statin therapy
• Lp(a)-lowering agents
• Novel lipid therapies
• Cardiovascular risk reduction
• Preventive cardiology in women
• Emerging pharmacologic approaches

Participants strengthen understanding of personalized cardiovascular prevention strategies.

---

Menopause, Pregnancy & Women’s Cardiovascular Risk

The course strongly emphasizes female-specific cardiovascular conditions.

Included Areas

• Menopause management
• Cardiovascular effects of menopause
• Hormonal therapy considerations
• Hypertension in pregnancy
• Postmenopausal hypertension
• Pregnancy-related cardiovascular disease

These sessions reinforce modern approaches to women-centered cardiovascular care.

---

GLP-1 Therapy, Weight Management & Cardiometabolic Health

Advanced discussions examine obesity treatment and cardiometabolic risk reduction.

Topics Covered

• Lifestyle modification
• GLP-1 receptor agonists
• Weight management debates
• Obesity and cardiovascular disease
• Cardiometabolic risk
• Evidence-based obesity therapies

The curriculum highlights modern preventive cardiology strategies for women.

---

Diversity, Equity & Women’s Cardiovascular Research

The symposium also addresses diversity in cardiovascular medicine.

Educational Themes

• Diversity in clinical trials
• Women in cardiovascular research
• Healthcare workforce diversity
• Sex- and gender-specific disparities
• Improving cardiovascular outcomes in women

Participants gain insight into broader public health and equity considerations in cardiovascular care.

---

Learning Objectives

Upon completion of this activity, participants should be able to:

• Apply current evidence to the diagnosis and management of MINOCA in women
• Evaluate statins and emerging Lp(a)-lowering therapies
• Integrate national recommendations for menopause management with cardiovascular comorbidities
• Assess lifestyle modification versus GLP-1 receptor agonist therapy for weight management
• Differentiate ACS symptom presentation in women versus men
• Demonstrate clinical decision-making for HFpEF, invasive coronary testing, and hypertension management in postmenopausal and pregnant women

---

Learning Experience

The symposium combines:

• Women’s cardiovascular medicine
• Ischemic heart disease
• Preventive cardiology
• Coronary physiology
• HFpEF management
• Lipidology
• Menopause medicine
• Cardio-obstetrics
• Case-based learning
• Interactive debates

The educational structure emphasizes practical clinical application and sex-specific cardiovascular care.

---

Who Should Enroll

This course is especially valuable for:

• Cardiologists
• OB/GYN physicians
• Preventive cardiologists
• Internists
• Women’s health clinicians
• Nurse practitioners
• Physician assistants
• Cardiovascular fellows
• Cardio-obstetrics specialists

It is particularly useful for clinicians interested in advancing expertise in women’s cardiovascular health and ischemic heart disease.

---

Why This Course Stands Out

Specialized Women’s Cardiovascular Focus

Concentrates specifically on sex-specific cardiovascular disease and ischemic syndromes in women.

Advanced Coronary Function Testing Education

Covers invasive physiologic assessment and coronary microvascular dysfunction.

Integration of Cardiology & Women’s Health

Bridges cardiovascular medicine with menopause, pregnancy, and preventive women’s healthcare.

Contemporary Preventive Cardiology Updates

Includes modern lipid therapies, GLP-1 agents, and cardiometabolic management strategies.

Case-Based & Debate-Oriented Learning

Uses practical discussions and controversies to reinforce clinical reasoning.

---

Clinical Value

The Cedars-Sinai 20th Annual Women and Ischemic Heart Disease Symposium 2026 delivers advanced cardiovascular education through integrated coverage of:

• Women’s ischemic heart disease
• MINOCA
• Coronary microvascular dysfunction
• HFpEF
• Preventive cardiology
• Lipid management
• Lp(a) therapies
• GLP-1 receptor agonists
• Menopause-associated cardiovascular risk
• Hypertension in pregnancy
• Acute coronary syndrome in women
• Coronary physiology testing

The combination of sex-specific cardiovascular education, evidence-based management strategies, advanced coronary diagnostics, and women-centered preventive cardiology makes this symposium highly valuable for clinicians caring for women with cardiovascular disease.

4. Topics

1. Case 1- Invasive Evaluation of HFpEF

2. Case 2- Invasive Coronary Function Testing

3. Case 3- Postmenopausal Woman with Labile HTN

4. Case 4- Pregnant Woman with HTN

5. Debate- Presentations of ACS Symptoms are Different Between Women and Men

6. How to Manage Menopause with Comorbidities, National Recommendations and New Drugs

7. MINOCA

8. Need for Diversity in Clinical Trials and Workforce

9. Statins and Lp(a) Drugs- What’s New-

10. Weight Loss Management Should Occur Primarily Through Lifestyle Modification Instead of GLP-1 Receptor Agonist Therapy